World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
15025
World Ranking
6439
National Ranking
3004

Raymond E. Meyn publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Raymond E. Meyn sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 234 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Raymond E. Meyn D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond E. Meyn sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Raymond E. Meyn was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focused primarily on medicine, with significant contributions in the fields of oncology, molecular biology, epidemiology, and surgery. The scientist's work concentrated on cancer-related molecular pathways, cervical cancer and HPV research, ubiquitin and proteasome pathways, PARP inhibition in cancer therapy, DNA repair mechanisms, colorectal and anal carcinomas, and epigenetics and DNA methylation.

Throughout their career, Meyn published several research papers in various scientific venues. Some of the notable publications included:

  • Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints (2020), published in the International Journal of Radiation Biology
  • p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade (2021), published in Cancer Research
  • p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade (2021), published in Research Square (Research Square)
  • p16 Expression Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. (2021), published in Research Square (Research Square)
  • p16 Expression Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. (2020), published in Research Square (Research Square)

Meyn frequently collaborated with a group of co-authors including Jessica M. Molkentine, David Molkentine, Kathleen A. Bridges, Aakash Sheth, and Kathryn A. Mason. These collaborations were reflected in multiple publications, often within the same research themes of DNA damage response and molecular signaling pathways.

Their work was disseminated across several journals and platforms, with the most common publication venues being:

  • Research Square (Research Square)
  • International Journal of Radiation Biology
  • Cancer Research

The scientist's research contributed to the understanding of mechanisms involved in DNA repair and molecular signaling related to cancer. The topics covered included:

  • Cancer-related Molecular Pathways
  • Cervical Cancer and HPV Research
  • Ubiquitin and proteasome pathways
  • PARP inhibition in cancer therapy
  • DNA Repair Mechanisms
  • Colorectal and Anal Carcinomas
  • Epigenetics and DNA Methylation

Best Publications

  • Radiation-induced apoptosis: Relevance to radiotherapy

    William C. Dewey;Clifton C. Ling;Raymond E. Meyn

  • Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine

    L. E. Robertson;Sherri Chubb;Raymond E. Meyn;Michael Story

  • Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.

    Anupama Munshi;John F. Kurland;Takashi Nishikawa;Toshimitsu Tanaka

  • Bcl-2 expression causes redistribution of glutathione to the nucleus

    D. W. Voehringer;D. J. McConkey;T. J. McDonnell;S. Brisbay

  • Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment

    Ann H. Klopp;Erika L. Spaeth;Jennifer L. Dembinski;Wendy A. Woodward

  • Clonogenic cell survival assay.

    Anupama Munshi;Marvette Hobbs;Raymond E. Meyn

  • TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

    Heath Skinner;Vlad C. Sandulache;Vlad C. Sandulache;Thomas J. Ow;Raymond E. Meyn

  • Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci

    Anupama Munshi;Toshimitsu Tanaka;Marvette L. Hobbs;Susan L. Tucker

  • Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.

    R. E. Meyn;L. C. Stephens;Kie-Kian Ang;N. R. Hunter

  • MK-1775, a novel wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells

    Kathleen A. Bridges;Hiroshi Hirai;Carolyn A. Buser;Colin Brooks

  • Apoptosis in irradiated murine tumors.

    L. C. Stephens;K. K. Ang;T. E. Schultheiss;L. Milas

  • Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols

    Nena Mirkovic;David W. Voehringer;Michael D. Story;David J. McConkey

  • Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.

    Luka Milas;Nancy R. Hunter;Belma Kurdoglu;Kathryn A. Mason

  • Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.

    Francis R. Spitz;Dao Nguyen;John M. Skibber;Raymond E. Meyn

  • Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo

    Tomoyuki Saeki;Abner Mhashilkar;Xin Swanson;X Helena Zou-Yang

  • Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II).

    Raymond E. Meyn;Peter M. Corry;Susan E. Fletcher;Marie Demetriades

  • Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

    Maria Angelica Abdalla Cortez;David Valdecanas;Xiaochun Zhang;Yanai Zhan

  • Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

    Toshimitsu Tanaka;Anupama Munshi;Colin Brooks;Jenny Liu

  • Development of apoptosis in irradiated murine tumors as a function of time and dose.

    L. C. Stephens;N. R. Hunter;K. Kian Ang;L. Milas

  • TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2

    Anupama Munshi;Gus Pappas;Tsuyoshi Honda;Timothy J McDonnell

Frequent Co-Authors

Luka Milas
Luka Milas The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Timothy J. McDonnell
Timothy J. McDonnell The University of Texas MD Anderson Cancer Center
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Thomas A. Buchholz
Thomas A. Buchholz The University of Texas MD Anderson Cancer Center
Sunil Chada
Sunil Chada The University of Texas MD Anderson Cancer Center
Jeffrey N. Myers
Jeffrey N. Myers The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Rajagopal Ramesh
Rajagopal Ramesh University of Oklahoma Health Sciences Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Raymond E. Meyn

Recently Published Articles